Cargando…

Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes

IMPORTANCE: Despite lacking robust evidence of effectiveness, health care systems in developed countries are funding holistic community health worker (CHW) social prescribing programs that address social needs and health behaviors as adjuncts to clinical care. OBJECTIVE: To determine whether a UK Na...

Descripción completa

Detalles Bibliográficos
Autores principales: Wildman, John, Wildman, Josephine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411296/
https://www.ncbi.nlm.nih.gov/pubmed/34468751
http://dx.doi.org/10.1001/jamanetworkopen.2021.26236
_version_ 1783747273836986368
author Wildman, John
Wildman, Josephine M.
author_facet Wildman, John
Wildman, Josephine M.
author_sort Wildman, John
collection PubMed
description IMPORTANCE: Despite lacking robust evidence of effectiveness, health care systems in developed countries are funding holistic community health worker (CHW) social prescribing programs that address social needs and health behaviors as adjuncts to clinical care. OBJECTIVE: To determine whether a UK National Health Service (NHS) CHW social prescribing program was associated with improved hemoglobin A(1c) (HbA(1c)) levels among patients with type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS: This cohort study with difference-in-differences analysis was conducted among 8086 patients (4752 in the referral program, 3334 in the control group) in 24 NHS primary care practices in a city in North East England. Patients aged 40 to 74 years with a diagnosis of type 2 diabetes were observed for 8 years, from 2011 through 2019. The statistical analysis was conducted between June 1, 2019, and January 31, 2021. INTERVENTIONS: A social prescribing program, launched in April 2015, enabling primary care staff to refer patients to CHW support to identify condition management and social needs goals and access voluntary and community sector support to address these goals. Intervention referral was only available in primary care practices in the city’s west. The control group included patients in the city’s east where referral was unavailable. MAIN OUTCOMES AND MEASURES: HbA(1c) level, a marker of glycemic control. RESULTS: A total of 8086 patients were included in the analysis (mean [SD] age, 57.8 [8.78] years; 3477 women [43%]; 6631 White patients [82%]). Mean (SD) baseline HbA(1c) levels were 7.56% (1.47%) in the referral program group and 7.44% (1.43%) in the control group. Following introduction of the social prescribing referral program, the referral group experienced an HbA(1c) reduction of −0.10 percentage points (95% CI, −0.17 to −0.03 percentage points) compared with the control group. The association increased over time: after 3 years the estimated association was −0.14 percentage points (95% CI, −0.24 to −0.03 percentage points). The association was stronger for White patients compared with non-White patients (−0.15 percentage points [95% CI, −0.26 to −0.04 percentage points] after 3 years), those with fewer additional comorbidities (−0.16 percentage points [95% CI, −0.29 to −0.04 percentage points] after 3 years), and those living in the most socioeconomically deprived areas (−0.19 percentage points [95% CI, −0.32 to −0.07 percentage points] after 3 years). CONCLUSIONS AND RELEVANCE: In this study of UK adults with type 2 diabetes, a social prescribing program with referral to CHWs targeting patients’ social needs and health behaviors was associated with improved HbA(1c) levels, suggesting that holistic CHW interventions may help to reduce the public health burden of type 2 diabetes.
format Online
Article
Text
id pubmed-8411296
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-84112962021-09-22 Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes Wildman, John Wildman, Josephine M. JAMA Netw Open Original Investigation IMPORTANCE: Despite lacking robust evidence of effectiveness, health care systems in developed countries are funding holistic community health worker (CHW) social prescribing programs that address social needs and health behaviors as adjuncts to clinical care. OBJECTIVE: To determine whether a UK National Health Service (NHS) CHW social prescribing program was associated with improved hemoglobin A(1c) (HbA(1c)) levels among patients with type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS: This cohort study with difference-in-differences analysis was conducted among 8086 patients (4752 in the referral program, 3334 in the control group) in 24 NHS primary care practices in a city in North East England. Patients aged 40 to 74 years with a diagnosis of type 2 diabetes were observed for 8 years, from 2011 through 2019. The statistical analysis was conducted between June 1, 2019, and January 31, 2021. INTERVENTIONS: A social prescribing program, launched in April 2015, enabling primary care staff to refer patients to CHW support to identify condition management and social needs goals and access voluntary and community sector support to address these goals. Intervention referral was only available in primary care practices in the city’s west. The control group included patients in the city’s east where referral was unavailable. MAIN OUTCOMES AND MEASURES: HbA(1c) level, a marker of glycemic control. RESULTS: A total of 8086 patients were included in the analysis (mean [SD] age, 57.8 [8.78] years; 3477 women [43%]; 6631 White patients [82%]). Mean (SD) baseline HbA(1c) levels were 7.56% (1.47%) in the referral program group and 7.44% (1.43%) in the control group. Following introduction of the social prescribing referral program, the referral group experienced an HbA(1c) reduction of −0.10 percentage points (95% CI, −0.17 to −0.03 percentage points) compared with the control group. The association increased over time: after 3 years the estimated association was −0.14 percentage points (95% CI, −0.24 to −0.03 percentage points). The association was stronger for White patients compared with non-White patients (−0.15 percentage points [95% CI, −0.26 to −0.04 percentage points] after 3 years), those with fewer additional comorbidities (−0.16 percentage points [95% CI, −0.29 to −0.04 percentage points] after 3 years), and those living in the most socioeconomically deprived areas (−0.19 percentage points [95% CI, −0.32 to −0.07 percentage points] after 3 years). CONCLUSIONS AND RELEVANCE: In this study of UK adults with type 2 diabetes, a social prescribing program with referral to CHWs targeting patients’ social needs and health behaviors was associated with improved HbA(1c) levels, suggesting that holistic CHW interventions may help to reduce the public health burden of type 2 diabetes. American Medical Association 2021-09-01 /pmc/articles/PMC8411296/ /pubmed/34468751 http://dx.doi.org/10.1001/jamanetworkopen.2021.26236 Text en Copyright 2021 Wildman J et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Wildman, John
Wildman, Josephine M.
Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes
title Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes
title_full Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes
title_fullStr Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes
title_full_unstemmed Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes
title_short Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes
title_sort evaluation of a community health worker social prescribing program among uk patients with type 2 diabetes
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411296/
https://www.ncbi.nlm.nih.gov/pubmed/34468751
http://dx.doi.org/10.1001/jamanetworkopen.2021.26236
work_keys_str_mv AT wildmanjohn evaluationofacommunityhealthworkersocialprescribingprogramamongukpatientswithtype2diabetes
AT wildmanjosephinem evaluationofacommunityhealthworkersocialprescribingprogramamongukpatientswithtype2diabetes